IMAGE: Lung squamous cell carcinoma

Breaking News

Key: Meeting M      Journal J      Funder F

Showing releases 1126-1150 out of 1184.

<< < 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 > >>

Public Release: 29-Nov-2012
Proceedings of the National Academy of Sciences
Researchers create a fly to study how a normal cell turns cancerous
The wing of a fruit fly may hold the key to unraveling the genetic and molecular events that transform a normal cell into a cancerous one. The study, conducted on Drosophila melanogaster by scientists at the IRB Barcelona has reproduced each of the steps known to take place when a healthy cell turns cancerous. The researchers have thus provided an inexpensive and effective model that will allow to scrutinize the genes and molecules involved in each step.

Contact: Sònia Armengou
armengou@irbbarcelona.org
34-934-037-255
Institute for Research in Biomedicine (IRB Barcelona)

Public Release: 29-Nov-2012
Cancer Cell
Study sheds light on how pancreatic cancer begins
Research led by scientists at the University of California, San Diego and UC San Francisco Schools of Medicine examined the tumor-initiating events leading to pancreatic cancer (also called pancreatic ductal adenocarcinoma or PDA) in mice. Their work, published on line November 29 in the journal Cancer Cell, may help in the search for earlier detection methods and treatments.
National Institutes of Health

Contact: Debra Kain
ddkain@ucsd.edu
619-543-6163
University of California - San Diego

Public Release: 29-Nov-2012
Cancer Cell
Study helps resolve debate about how tumors spread
A team of scientists, led by researchers at the University of California, San Diego School of Medicine, has shown for the first time how cancer cells control the ON/OFF switch of a program used by developing embryos to effectively metastasize in vivo, breaking free and spreading to other parts of the body, where they can proliferate and grow into secondary tumors.
National Institutes of Health, American Cancer Society, Sidney Kimmel Foundation for Cancer

Contact: Scott LaFee
slafee@ucsd.edu
619-543-6163
University of California - San Diego

Public Release: 29-Nov-2012
Stress and Health
Meditation with art therapy can change your brain and lower anxiety
Cancer and stress go hand-in-hand, and high stress levels can lead to poorer health outcomes in cancer patients. The Jefferson-Myrna Brind Center of Integrative Medicine combined creative art therapy with a Mindfulness-based Stress Reduction program for women with breast cancer and showed changes in brain activity associated with lower stress and anxiety after the eight-week program. Their new study appears in the December issue of the journal Stress and Health.

Contact: Lee-Ann Landis
leeann.landis@jefferson.edu
215-955-2240
Thomas Jefferson University

Public Release: 29-Nov-2012
FASEB Journal
New genetic test detects early breast cancer and identifies future risk
Breast cancer detection has improved, but more work remains to ensure accurate diagnosis, and to assess future risk. Researchers are developing a test of gene action that predicts cancer risk at first diagnosis, and into the future. This research in The FASEB Journal discusses how genetic switches, which are turned on and off in regular cellular development, can be analyzed in minute detail to determine the presence, or risk, of breast cancer growth.

Contact: Cody Mooneyhan
cmooneyhan@faseb.org
301-634-7104
Federation of American Societies for Experimental Biology

Public Release: 29-Nov-2012
Journal of Ovarian Research
Understanding of the mechanisms of drug resistance to dual-agent chemotherapy in ovarian cancer
A study published today in the open-access Journal of Ovarian Research provides novel information that further adds to clinicians' understanding of the mechanisms involved in the development of resistance to dual-agent chemotherapy.

Contact: Hilary Glover
hilary.glover@biomedcentral.com
44-020-319-22370
BioMed Central

Public Release: 29-Nov-2012
Journal of Clinical Oncology
Delayed treatment for advanced breast cancer has 'profound effect'
Results from a recent study show women who wait more than 60 days to begin treatment for advanced breast cancer face significantly higher risks of dying than women who start therapy shortly after diagnosis.

Contact: Marti Leitch
Marti.Leitch@osumc.edu
614-293-3737
Ohio State University Medical Center

Public Release: 29-Nov-2012
American Journal of Pathology
St. Joseph's researchers identify gene involved in lung tumor growth
Lung cancer researchers at St. Joseph's Hospital and Medical Center in Phoenix, Ariz., in collaboration with researchers at the Translational Genomics Research Institute and other institutions, have identified a gene that plays a role in the growth and spread of non-small cell lung cancer tumors, opening the door for potential new treatment options.

Contact: Sara Baird
sara.baird@dignityhealth.org
602-406-3312
St. Joseph's Hospital and Medical Center

Public Release: 29-Nov-2012
Journal of Biological Chemistry
Activating ALC1: With a little help from friends
Chromatin remodeling -- the packaging and unpackaging of genomic DNA and its associated proteins -- regulates a host of fundamental cellular processes including gene transcription, DNA repair, programmed cell death as well as cell fate. In their latest study, scientists at the Stowers Institute for Medical Research are continuing to unravel the finicky details of how these architectural alterations are controlled.
NIH/National Institute of General Medical Sciences, Helen Nelson Medical Research Fund

Contact: Gina Kirchweger
gxk@stowers.org
816-806-1036
Stowers Institute for Medical Research

Public Release: 29-Nov-2012
Structure
Proteins that work at the ends of DNA could provide cancer insight
New insights into a protein complex that regulates the very tips of chromosomes could improve methods of screening anti-cancer drugs. University of Illinois researchers determined the binding mechanism of proteins that protect and regulate telomeres, segments of repeating DNA units that cap the ends of chromosomes and a key target of cancer researchers.
American Cancer Society, Human Frontier Science Research Program

Contact: Liz Ahlberg
eahlberg@illinois.edu
217-244-1073
University of Illinois at Urbana-Champaign

Public Release: 29-Nov-2012
Population Health Management
Diabetics with cancer dangerously ignore blood sugar
When people with Type 2 diabetes are diagnosed with cancer -- for which they are at higher risk -- they ignore their diabetes to focus on cancer. But high blood sugar is more likely to kill them. When they received diabetes education after a cancer diagnosis, however, they were more likely to monitor their blood sugar and had fewer visits to the emergency room, fewer hospital admissions and lower health care costs.
NIH/National Cancer Institute

Contact: Marla Paul
marla-paul@northwestern.edu
312-503-8928
Northwestern University

Public Release: 28-Nov-2012
Journal of the National Cancer Institute
Combined RB and PTEN loss identifies DCIS primed for invasive breast cancer
The combined loss of two tumor suppressor genes, retinoblastoma and phosphatase and tensin homolog was shown to be strongly associated with progression of DCIS to invasive breast cancer, according to a study published Nov. 28 in the Journal of the National Cancer Institute.

Contact: Zachary Rathner
Zachary.Rathner@oup.com
301-841-1286
Journal of the National Cancer Institute

Public Release: 28-Nov-2012
Nature
COUP-TFII sparks prostate cancer progression
Which cancers are essentially indolent and present no risk and which are life threatening? Which can be watched and which need aggressive treatment? Drs. Ming-Jer and Sophia Tsai both professors in the department of molecular and cellular biology at Baylor College of Medicine, think a receptor called COUP-TFII that they have long studied may point the way to an answer.

Contact: Dipali Pathak
pathak@bcm.edu
713-713-4710
Baylor College of Medicine

Public Release: 28-Nov-2012
Journal of the National Cancer Institute
NSAID use linked to reduced hepatocellular carcinoma risk and mortality due to chronic liver disease
Researchers found that aspirin use is associated with a decreased risk of developing hepatocellular carcinoma and death from chronic liver disease, according to a study published Nov. 28 in the Journal of the National Cancer Institute.

Contact: Zachary Rathner
Zachary.Rathner@oup.com
301-841-1286
Journal of the National Cancer Institute

Public Release: 28-Nov-2012
Environmental Science and Technology
New study: Many flame retardants in house dust -- unsafe levels
In Silent Spring Institute's new peer-reviewed study of the largest number of flame retardants ever tested in homes, we found that most houses had levels of at least one flame retardant that exceeded a federal health guideline.
NIH/National Institute of Environmental Health Sciences, New York Community Trust, Fine Fund, Art beCAUS

Contact: Kathryn Rodgers
rodgers@silentspring.org
617-332-4288 x225
Silent Spring Institute

Public Release: 28-Nov-2012
Potentially toxic flame retardants found in many US couches
More than half of all couches tested in a Duke University-led study contained potentially toxic or untested chemical flame retardants that may pose risks to human health.
NIH/National Institute of Environmental Health Sciences

Contact: Tim Lucas
tdlucas@duke.edu
919-613-8084
Duke University

Public Release: 28-Nov-2012
Journal of the National Cancer Institute
KRAS and BRAF mutation screening in metastatic colorectal cancer costly in relation to benefits
Researchers report that screening for KRAS and BRAF mutations can reduce the cost of anti-EGFR treatment for metastatic colorectal cancer but with a very small reduction in overall survival according to a new study published on Nov. 28 in the Journal of the National Cancer Institute.

Contact: Zachary Rathner
Zachary.Rathner@oup.com
301-841-1286
Journal of the National Cancer Institute

Public Release: 28-Nov-2012
Journal of Lipid Research
Analysis of conflicting fish oil studies finds that omega-3 fatty acids still matter
A new analysis helps to sort through conflicting findings from literally hundreds of studies on use of omega-3 fatty acids for heart disease. It concludes that they still matter; they do work; and that modern therapies for cardiovascular disease help to mask the benefits omega-3 consumption might otherwise provide.
National Institutes of Health, US Department of Agriculture

Contact: Donald Jump
Donald.Jump@oregonstate.edu
541-737-4007
Oregon State University

Public Release: 28-Nov-2012
Lancet Oncology
Researchers report first success of targeted therapy in most common non-small cell lung cancer
A new study by an international team of investigators led by Dana-Farber Cancer Institute scientists is the first to demonstrate that chemotherapy and a new, targeted therapy work better in combination than chemotherapy alone in treating patients with the most common genetic subtype of lung cancer.
AstraZeneca

Contact: Robbin Ray
Robbin_Ray@dfci.harvard.edu
617-632-4090
Dana-Farber Cancer Institute

Public Release: 28-Nov-2012
Radiology
Experts recommend closer scrutiny of radiation exposure from CT scans
Amid increasing fear of overexposure to radiation from CT scans, a panel of experts has recommended more research on the health effects of medical imaging and ways to reduce unnecessary CT tests, as well as industry standardization of CT machines.
University of California

Contact: Dorsey Griffith
dorsey.griffith@ucdmc.ucdavis.edu
916-734-9118
University of California - Davis Health System

Public Release: 28-Nov-2012
Science Translational Medicine
Johns Hopkins scientists pair blood test and gene sequencing to detect cancer
Scientists at the Johns Hopkins Kimmel Cancer Center have combined the ability to detect cancer DNA in the blood with genome sequencing technology in a test that could be used to screen for cancers, monitor cancer patients for recurrence and find residual cancer left after surgery.
National Institutes of Health

Contact: Vanessa Wasta
wasta@jhmi.edu
410-614-2916
Johns Hopkins Medicine

Public Release: 28-Nov-2012
2012 Quality Care Symposium
Studies from 2012 Quality Care Symposium highlight findings in improving quality of cancer care
Five additional studies to be presented at the 2012 Quality Care Symposium provide insight on how oncology practices can improve the quality of care they provide. The Symposium will take place Nov. 30 - Dec. 1, at the Manchester Grand Hyatt in San Diego.

Contact: Aaron Tallent
Aaron.Tallent@asco.org
619-358-6782
American Society of Clinical Oncology

Public Release: 28-Nov-2012
Journal of Biological Chemistry
Scripps Florida scientists uncover a novel cooperative effort to stop cancer spread
Scientists from the Florida campus of The Scripps Research Institute have uncovered a group of what have been considered relatively minor regulators in the body that band together to suppress the spread of cancer from its primary site.
National Institutes of Health

Contact: Eric Sauter
esauter@scripps.edu
267-337-3859
Scripps Research Institute

Public Release: 28-Nov-2012
New England Journal of Medicine
Ponatinib acts against the most resistant types of chronic myeloid leukemia
A previously invincible mutation in chronic myeloid leukemia has been thwarted by an investigational drug in a phase I clinical trial reported in the current edition of the New England Journal of Medicine.

Contact: Scott Merville
smerville@mdanderson.org
713-792-0661
University of Texas M. D. Anderson Cancer Center

Public Release: 27-Nov-2012
2012 Quality Care Symposium
Research from ASCO'S Quality Care Symposium shows advances and challenges in improving the quality of cancer care
New studies released today reveal important advances in cancer care quality measurement, physician adherence to quality standards, and end-of-life care, while highlighting the overuse of contralateral prophylactic mastectomy. The studies were released in a presscast today in advance of ASCO's inaugural 2012 Quality Care Symposium. The Symposium will take place Nov. 30 – Dec. 1, 2012, at the Manchester Grand Hyatt in San Diego.

Contact: Aaron Tallent
Aaron.Tallent@asco.org
571-483-1371
American Society of Clinical Oncology

Showing releases 1126-1150 out of 1184.

<< < 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 > >>

  Search News Releases

     

 

 

EurekAlert!